Oxidative stress-modulating drugs have preferential anticancer effects-involving the regulation of apoptosis, DNA damage, endoplasmic reticulum stress, autophagy, metabolism … JY Tang, F Ou-Yang, MF Hou, HW Huang, HR Wang, KT Li, S Fayyaz, ... Seminars in cancer biology 58, 109-117, 2019 | 189 | 2019 |
Rutin mediated targeting of signaling machinery in cancer cells AA Perk, I Shatynska-Mytsyk, YC Gerçek, K Boztaş, M Yazgan, S Fayyaz, ... Cancer cell international 14, 1-5, 2014 | 127 | 2014 |
Anticancer drugs for the modulation of endoplasmic reticulum stress and oxidative stress AA Farooqi, KT Li, S Fayyaz, YT Chang, M Ismail, CC Liaw, SSF Yuan, ... Tumor Biology 36, 5743-5752, 2015 | 125 | 2015 |
Oleuropein and cancer chemoprevention: the link is hot A Ahmad Farooqi, S Fayyaz, AS Silva, A Sureda, SF Nabavi, A Mocan, ... Molecules 22 (5), 705, 2017 | 72 | 2017 |
Targeting Programmed Fusobacterium nucleatum Fap2 for Colorectal Cancer Therapy K Ganesan, S Guo, S Fayyaz, G Zhang, B Xu Cancers 11 (10), 1592, 2019 | 53 | 2019 |
Is miR‐34a a well‐equipped swordsman to conquer temple of molecular oncology? AA Farooqi, S Fayyaz, I Shatynska‐Mytsyk, Z Javed, S Jabeen, I Yaylim, ... Chemical biology & drug design 87 (3), 321-334, 2016 | 52 | 2016 |
Natural products are the future of anticancer therapy: Preclinical and clinical advancements of Viscum album phytometabolites R Attar, S Tabassum, S Fayyaz, MS Ahmad, DR Nogueira, I Yaylim, ... Cellular and Molecular Biology 61 (6), 62-68, 2015 | 49 | 2015 |
Reactive oxygen species and autophagy modulation in non-marine drugs and marine drugs AA Farooqi, S Fayyaz, MF Hou, KT Li, JY Tang, HW Chang Marine Drugs 12 (11), 5408-5424, 2014 | 48 | 2014 |
Epigenetic deregulation in cancer: Enzyme players and non-coding RNAs AA Farooqi, S Fayyaz, P Poltronieri, G Calin, M Mallardo Seminars in cancer biology 83, 197-207, 2022 | 44 | 2022 |
Interplay between epigenetic abnormalities and deregulated expression of microRNAs in cancer AA Farooqi, E Fuentes-Mattei, S Fayyaz, P Raj, M Goblirsch, P Poltronieri, ... Seminars in cancer biology 58, 47-55, 2019 | 43 | 2019 |
TRAIL, Wnt, sonic hedgehog, TGFβ, and miRNA signalings are potential targets for oral cancer therapy AA Farooqi, CW Shu, HW Huang, HR Wang, YT Chang, S Fayyaz, ... International Journal of Molecular Sciences 18 (7), 1523, 2017 | 32 | 2017 |
Oleuropein mediated targeting of signaling network in cancer S Fayyaz, T Aydin, A Cakir, ML Gasparri, P Benedetti Panici, ... Current Topics in Medicinal Chemistry 16 (22), 2477-2483, 2016 | 31 | 2016 |
VEGF mediated signaling in oral cancer X Lin, S Khalid, MZ Qureshi, R Attar, I Yaylim, I Ucak, A Yaqub, S Fayyaz, ... Cellular and Molecular Biology 62 (14), 64-68, 2016 | 24 | 2016 |
Anticancer activity of essential oils: targeting of protein networks in cancer cells A Aras, MJ Iqbal, SKH Naqvi, YC Gercek, K Boztas, ML Gasparri, ... Asian Pacific Journal of Cancer Prevention 15 (19), 8047-8050, 2014 | 18 | 2014 |
miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells S Fayyaz, AA Farooqi Immunogenetics 65, 315-332, 2013 | 18 | 2013 |
MicroRNA regulation of TRAIL mediated signaling in different cancers: Control of micro steering wheels during the journey from bench-top to the bedside S Fayyaz, Z Javed, R Attar, AA Farooqi, I Yaylim, A Ahmad Seminars in Cancer Biology 58, 56-64, 2019 | 17 | 2019 |
Interplay of long non-coding RNAs and TGF/SMAD signaling in different cancers AA Farooqi, R Attar, MZ Qureshi, S Fayyaz, MI Sohail, UY Sabitaliyevich, ... Cellular and Molecular Biology 64 (15), 1-6, 2018 | 17 | 2018 |
TRAIL based therapy: overview of mesenchymal stem cell based delivery and miRNA controlled expression of TRAIL R Attar, F Sajjad, MZ Qureshi, F Tahir, E Hussain, S Fayyaz, AA Farooqi Asian Pacific Journal of Cancer Prevention 15 (16), 6495-6497, 2014 | 17 | 2014 |
New frontiers in promoting TRAIL-mediated cell death: Focus on natural sensitizers, miRNAs, and nanotechnological advancements AA Farooqi, CD Gadaleta, G Ranieri, S Fayyaz, I Marech Cell biochemistry and biophysics 74, 3-10, 2016 | 15 | 2016 |
Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and death receptor (DR4) genes contribute to susceptibility to colorectal cancer in … A Zahoor, Q Mansoor, AA Farooqi, S Fayyaz, G Naz, M Ismail Cellular and Molecular Biology 61 (6), 108-112, 2015 | 15 | 2015 |